Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation (Q34646976)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation (English)

1 reference

Europe PubMed Central

3 August 2017

Norah A Terrault

2

object named as

Norah Terrault

1 reference

Europe PubMed Central

3 August 2017

author name string

Michael R Lucey

1

1 reference

Europe PubMed Central

3 August 2017

Lolu Ojo

3

1 reference

Europe PubMed Central

3 August 2017

J Eileen Hay

4

1 reference

Europe PubMed Central

3 August 2017

James Neuberger

5

1 reference

Europe PubMed Central

3 August 2017

Emily Blumberg

6

1 reference

Europe PubMed Central

3 August 2017

Lewis W Teperman

7

1 reference

Europe PubMed Central

3 August 2017

publication date

1 January 2013

1 reference

Europe PubMed Central

3 August 2017

Liver Transplantation

1 reference

Europe PubMed Central

3 August 2017

19

1 reference

Europe PubMed Central

3 August 2017

1

1 reference

Europe PubMed Central

3 August 2017

3-26

1 reference

Europe PubMed Central

3 August 2017

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Chronic renal failure after transplantation of a nonrenal organ

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Quality of life after liver transplantation. A systematic review

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Biliary casts after orthotopic liver transplantation: clinical factors, treatment, biochemical analysis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Liver biopsy interpretation for causes of late liver allograft dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Bone mineral density before and after OLT: long-term follow-up and predictive factors.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network database.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Advances in glomerular filtration rate-estimating equations

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Risk factors and consequences of post-transplant diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Posttransplantation hypertension related to calcineurin inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: results of a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Metabolic syndrome and liver transplantation: a review and guide to management

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Weight gain and obesity after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Weight change and obesity after liver transplantation: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Spectrum of cancer risk among US solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Long-term probability of and mortality from de novo malignancy after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Incidence and management of colorectal cancer in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Recovery of menstruation and pregnancy after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure?

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Sexual health after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Pregnancy outcomes among liver transplant recipients in the United States: a nationwide case-control analysis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Pregnancy and sexual function in liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Laboratory diagnosis of invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Antigen assay with the potential to aid in diagnosis of blastomycosis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Detection of histoplasma antigen by a quantitative enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Pneumocystis pneumonia in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Mycobacterium tuberculosis infection in liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Liver transplantation in HIV-HCV coinfected patients: a case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Trends in waiting list registration for liver transplantation for viral hepatitis in the United States

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

The option of HBIG-free prophylaxis against recurrent HBV

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Treating hepatitis C infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

The association between hepatitis C infection and survival after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Recurrent primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Recurrence and rejection in liver transplantation for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Liver transplantation in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Nonalcoholic fatty liver disease and liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Defining the outcome of immunosuppression withdrawal after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal

1 reference

https://api.crossref.org/works/10.1002%2FLT.23566

21 January 2018

Identifiers

10.1002/LT.23566

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34646976&oldid=1999400369"